This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Mar;45(3):827-9.

doi: 10.1002/hep.21618.

Pioglitazone for patients with type 2 diabetes and nonalcoholic steatohepatitis

Janet King¹, Kris V Kowdley

Affiliations

PMID: 17326209
DOI: 10.1002/hep.21618

Comment

Pioglitazone for patients with type 2 diabetes and nonalcoholic steatohepatitis

Janet King et al. Hepatology. 2007 Mar.

. 2007 Mar;45(3):827-9.

doi: 10.1002/hep.21618.

Authors

Janet King¹, Kris V Kowdley

Affiliation

¹ University of Washington School of Medicine, Seattle, WA, USA.

PMID: 17326209
DOI: 10.1002/hep.21618

No abstract available

PubMed Disclaimer

Comment on

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. Belfort R, et al. N Engl J Med. 2006 Nov 30;355(22):2297-307. doi: 10.1056/NEJMoa060326. N Engl J Med. 2006. PMID: 17135584 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley